118 related articles for article (PubMed ID: 24486183)
21. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder.
Benedetti F; Bollettini I; Barberi I; Radaelli D; Poletti S; Locatelli C; Pirovano A; Lorenzi C; Falini A; Colombo C; Smeraldi E
Neuropsychopharmacology; 2013 Jan; 38(2):313-27. PubMed ID: 22990942
[TBL] [Abstract][Full Text] [Related]
22. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
Scassellati C; Rotondo A; Bonvicini C; Rossi G; Cassano GB; Gennarelli M
Psychiatr Genet; 2007 Aug; 17(4):249-50. PubMed ID: 17621172
[No Abstract] [Full Text] [Related]
23. Association between affective temperaments and brain-derived neurotrophic factor, glycogen synthase kinase 3β and Wnt signaling pathway gene polymorphisms in healthy subjects.
Tsutsumi T; Terao T; Hatanaka K; Goto S; Hoaki N; Wang Y
J Affect Disord; 2011 Jun; 131(1-3):353-7. PubMed ID: 21115199
[TBL] [Abstract][Full Text] [Related]
24. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.
Adli M; Hollinde DL; Stamm T; Wiethoff K; Tsahuridu M; Kirchheiner J; Heinz A; Bauer M
Biol Psychiatry; 2007 Dec; 62(11):1295-302. PubMed ID: 17628506
[TBL] [Abstract][Full Text] [Related]
25. β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.
Pedrosa E; Shah A; Tenore C; Capogna M; Villa C; Guo X; Zheng D; Lachman HM
J Neurogenet; 2010 Dec; 24(4):182-93. PubMed ID: 20615089
[TBL] [Abstract][Full Text] [Related]
26. Impulse control disorder comorbidity among patients with bipolar I disorder.
Karakus G; Tamam L
Compr Psychiatry; 2011; 52(4):378-85. PubMed ID: 21683175
[TBL] [Abstract][Full Text] [Related]
27. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder.
Swann AC; Dougherty DM; Pazzaglia PJ; Pham M; Steinberg JL; Moeller FG
Am J Psychiatry; 2005 Sep; 162(9):1680-7. PubMed ID: 16135628
[TBL] [Abstract][Full Text] [Related]
28. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
[TBL] [Abstract][Full Text] [Related]
29. Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.
Iwahashi K; Nishizawa D; Narita S; Numajiri M; Murayama O; Yoshihara E; Onozawa Y; Nagahori K; Fukamauchi F; Ikeda K; Ishigooka J
Clin Neuropharmacol; 2014; 37(4):108-10. PubMed ID: 24992082
[TBL] [Abstract][Full Text] [Related]
30. Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.
Liu S; Sun N; Xu Y; Yang C; Ren Y; Liu Z; Cao X; Sun Y; Xu Q; Zhang K; Shen Y
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1382-9. PubMed ID: 23030648
[TBL] [Abstract][Full Text] [Related]
31. Relationship of trait impulsivity with clinical presentation in euthymic bipolar disorder patients.
Ekinci O; Albayrak Y; Ekinci AE; Caykoylu A
Psychiatry Res; 2011 Dec; 190(2-3):259-64. PubMed ID: 21724267
[TBL] [Abstract][Full Text] [Related]
32. Increase in GSK3beta gene copy number variation in bipolar disorder.
Lachman HM; Pedrosa E; Petruolo OA; Cockerham M; Papolos A; Novak T; Papolos DF; Stopkova P
Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):259-65. PubMed ID: 17357145
[TBL] [Abstract][Full Text] [Related]
33. GSK3β genetic variability in patients with Multiple Sclerosis.
Galimberti D; Macmurray J; Scalabrini D; Fenoglio C; De Riz M; Comi C; Comings D; Cortini F; Villa C; Serpente M; Cantoni C; Ridolfi E; Fardipoor MH; Leone M; Monaco F; Bresolin N; Scarpini E
Neurosci Lett; 2011 Jun; 497(1):46-8. PubMed ID: 21527318
[TBL] [Abstract][Full Text] [Related]
34. Impulsivity predicts illness severity in long-term course of bipolar disorder: A prospective approach.
Rote J; Dingelstadt AM; Aigner A; Bauer M; Fiebig J; König B; Kunze J; Pfeiffer S; Pfennig A; Quinlivan E; Simhandl C; Stamm TJ
Aust N Z J Psychiatry; 2018 Sep; 52(9):876-886. PubMed ID: 29969910
[TBL] [Abstract][Full Text] [Related]
35. The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients.
Malloy-Diniz LF; Neves FS; de Moraes PH; De Marco LA; Romano-Silva MA; Krebs MO; Corrêa H
J Affect Disord; 2011 Sep; 133(1-2):221-6. PubMed ID: 21550122
[TBL] [Abstract][Full Text] [Related]
36. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
[TBL] [Abstract][Full Text] [Related]
37. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.
Su Y; Ryder J; Li B; Wu X; Fox N; Solenberg P; Brune K; Paul S; Zhou Y; Liu F; Ni B
Biochemistry; 2004 Jun; 43(22):6899-908. PubMed ID: 15170327
[TBL] [Abstract][Full Text] [Related]
38. Regulation of glycogen synthase kinase-3 during bipolar mania treatment.
Li X; Liu M; Cai Z; Wang G; Li X
Bipolar Disord; 2010 Nov; 12(7):741-52. PubMed ID: 21040291
[TBL] [Abstract][Full Text] [Related]
39. Higher Impulsivity and HIV-Risk Taking Behaviour in Males with Alcohol Dependence Compared to Bipolar Mania: A Pilot Study.
Rai S; Mishra BR; Sarkar S; Praharaj SK; Das S; Maiti R; Agrawal N; Nizami SH
Community Ment Health J; 2018 Feb; 54(2):218-223. PubMed ID: 28456858
[TBL] [Abstract][Full Text] [Related]
40. Trait impulsivity in patients with mood disorders.
Peluso MA; Hatch JP; Glahn DC; Monkul ES; Sanches M; Najt P; Bowden CL; Barratt ES; Soares JC
J Affect Disord; 2007 Jun; 100(1-3):227-31. PubMed ID: 17097740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
